Ann-Lise drives industry engagement on health and environmental policy and plays a leading role in advancing innovation-friendly R&D ecosystems. Her work focuses on shaping policy and advocacy strategies and strengthening engagement with international stakeholders, including WHO, OECD, the private sector, and civil society.
Prior to joining IFPMA, Ann-Lise worked with Sanofi Global Health’s Public Affairs team, supporting policy engagement around its portfolio in non-communicable diseases, tuberculosis, malaria, and antimicrobial resistance. She also completed a recent assignment with Roche’s Global Policy Team.
A hospital pharmacist by training, Ann-Lise brings experience across market access, medical affairs, and health economics, gained at MSD France and the French Health Technology Assessment Agency (Haute Autorité de Santé), as well as clinical experience at the University Hospitals of Bordeaux and Toulouse.
She holds a PharmD specializing in Hospital Pharmacy from the Université Paul Sabatier in Toulouse, complemented by qualifications in health economics, statistics for medical trials, and climate change and economic governance.
Working at IFPMA allows me to interact with incredibly skilled and expert colleagues, members, and external stakeholders. Its status offers the opportunity to collaborate with a wide range of key global health actors, whose shared objectives foster constructive cross-sectoral agendas.
More from Ann-Lise
Dialogue on global diabetes care with James Anderson: What is needed as we mark another World Diabetes Day?
For World Diabetes Day on 14 November, Ann-Lise Mikolajczak, Associate Manager, Value and Access and James Anderson, Executive Director of Global Health, sat down to discuss global diabetes care. This Q&A was developed in collaboration with HYPER Network, a platform for young industry professionals.
Read moreNew collaboration to improve access to quality cancer management in LMICs
This blog was originally published on 28 June by Media Planet in Global Cause and as a supplement to The Guardian. There is a huge gap in cancer mortality rates between high and lower-resource settings, with 70% of global cancer deaths occurring in low- and middle-income countries (LMICs). The gap in cancer mortality rates is...
Read more
Renewing industry’s commitment to better access to diabetes care on World Diabetes Day
This World Diabetes Day (WDD), IFPMA and its members are renewing our commitment to take proactive steps to improve access to diabetes care and make progress toward the achievement of SDG target 3.4.
Read more